Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $0.99 -0.04 (-3.54%) Closing price 04/17/2025 03:58 PM EasternExtended Trading$0.98 -0.01 (-1.36%) As of 04/17/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Stock Price Performance 5 Day Performance-10.50%1 Month Performance-21.16%3 Month Performance-54.43%6 Month Performance-35.07%Year-To-Date Performance-55.84%1 Year Performance+46.17% Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. Email Address VRAX Stock Chart for Friday, April, 18, 2025 VRAX Chart by TradingView Virax Biolabs Group Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/17/2025$1.03$0.99-3.54%$1.05$0.95183,520 shs$3.21 million04/16/2025$1.06$1.03-2.83%$1.05$1.0036,033 shs$3.33 million04/15/2025$1.02$1.06+3.92%$1.09$0.9777,555 shs$3.43 million04/14/2025$1.11$1.02-8.11%$1.07$0.99260,155 shs$3.30 million04/11/2025$0.88$1.11+25.99%$1.34$0.944.36 million shs$3.59 million04/10/2025$0.88$0.88$0.93$0.8530,707 shs$2.85 million04/09/2025$0.88$0.88+0.54%$0.88$0.8250,221 shs$2.85 million04/09/2025$0.88$0.88+0.54%$0.88$0.8250,221 shs$2.85 million04/08/2025$0.92$0.88-4.75%$0.98$0.8646,228 shs$2.83 million04/08/2025$0.92$0.88-4.75%$0.98$0.8646,228 shs$2.83 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 04/07/2025$0.98$0.92-5.69%$0.96$0.8587,750 shs$2.97 million04/04/2025$1.03$0.98-5.29%$1.04$0.9163,631 shs$3.15 million04/03/2025$1.14$1.03-9.65%$1.10$1.01105,594 shs$3.33 million04/02/2025$1.10$1.14+3.83%$1.14$1.0761,051 shs$3.69 million04/01/2025$1.14$1.10-3.69%$1.14$1.07185,002 shs$3.55 million03/31/2025$1.16$1.14-1.72%$1.24$1.1467,267 shs$3.69 million03/28/2025$1.24$1.16-6.45%$1.29$1.10154,337 shs$3.75 million03/27/2025$1.27$1.24-2.36%$1.30$1.2241,757 shs$4.01 million03/26/2025$1.29$1.27-1.55%$1.35$1.2643,700 shs$4.11 million03/25/2025$1.28$1.29+0.78%$1.35$1.27112,515 shs$4.17 million03/24/2025$1.22$1.28+4.92%$1.29$1.2352,853 shs$4.14 million03/21/2025$1.27$1.22-3.94%$1.29$1.2042,604 shs$3.94 million03/20/2025$1.23$1.27+3.25%$1.27$1.2121,965 shs$4.11 million03/19/2025$1.26$1.23-2.39%$1.27$1.2282,076 shs$3.98 million03/18/2025$1.28$1.26-1.55%$1.34$1.2596,170 shs$4.07 million03/17/2025$1.37$1.28-6.57%$1.43$1.25275,295 shs$4.14 million Related Companies Spruce Biosciences Stock Chart IN8bio Stock Chart Quantum Biopharma Stock Chart Synlogic Stock Chart Affimed Stock Chart MEI Pharma Stock Chart Imunon Stock Chart Calidi Biotherapeutics Stock Chart Orgenesis Stock Chart Sol-Gel Technologies Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Last Time Stocks Looked Like This, They Didn’t Move For 16 YearsThere is nothing the Federal Reserve can do to stop what's coming next for U.S. stocks. As you've seen your...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThey Won’t Tell You This About GoldInflation, digital currency, and government policy are quietly eating away at your savings — and most people w...American Alternative | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
